Published in Mol Psychiatry on January 20, 2015
Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment. Biol Psychiatry (2016) 0.86
GABA interneurons mediate the rapid antidepressant-like effects of scopolamine. J Clin Invest (2016) 0.85
Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state. Mol Psychiatry (2016) 0.81
Impact of anxiety on prefrontal cortex encoding of cognitive flexibility. Neuroscience (2016) 0.79
Sex-Dependent Anti-Stress Effect of an α5 Subunit Containing GABAA Receptor Positive Allosteric Modulator. Front Pharmacol (2016) 0.78
Decreased Numbers of Somatostatin-Expressing Neurons in the Amygdala of Subjects With Bipolar Disorder or Schizophrenia: Relationship to Circadian Rhythms. Biol Psychiatry (2016) 0.78
Neuron-Microglia Interactions in Mental Health Disorders: "For Better, and For Worse". Front Immunol (2016) 0.75
C-type allatostatins mimic stress-related effects of alarm pheromone on honey bee learning and memory recall. PLoS One (2017) 0.75
Chronic mild stress alters the somatostatin receptors in the rat brain. Psychopharmacology (Berl) (2016) 0.75
Roles of Hippocampal Somatostatin Receptor Subtypes in Stress Response and Emotionality. Neuropsychopharmacology (2016) 0.75
Prefrontal Cortex GABAergic Deficits and Circuit Dysfunction in the Pathophysiology and Treatment of Chronic Stress and Depression. Curr Opin Behav Sci (2017) 0.75
Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective. Biol Psychiatry (2017) 0.75
Decrease in somatostatin-positive cell density in the amygdala of females with major depression. Depress Anxiety (2016) 0.75
Sex-specific transcriptional signatures in human depression. Nat Med (2017) 0.75
Somatostatin-IRES-Cre Mice: Between Knockout and Wild-Type? Front Endocrinol (Lausanne) (2017) 0.75
Age-Related Gene Expression in the Frontal Cortex Suggests Synaptic Function Changes in Specific Inhibitory Neuron Subtypes. Front Aging Neurosci (2017) 0.75
Somatostatin-Positive Gamma-Aminobutyric Acid Interneuron Deficits in Depression: Cortical Microcircuit and Therapeutic Perspectives. Biol Psychiatry (2017) 0.75
Rapid Acting Antidepressants in Chronic Stress Models: Molecular and Cellular Mechanisms. Chronic Stress (Thousand Oaks) (2017) 0.75
Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol (2007) 33.06
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (2003) 28.61
Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell (2000) 17.44
IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature (2002) 16.52
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science (2003) 16.14
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry (2006) 12.41
The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry (2003) 10.60
A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science (2005) 7.98
Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry (1999) 7.87
A resource of Cre driver lines for genetic targeting of GABAergic neurons in cerebral cortex. Neuron (2011) 6.93
Major depressive disorder. N Engl J Med (2008) 6.61
Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry (2003) 6.52
A molecular and cellular theory of depression. Arch Gen Psychiatry (1997) 6.10
Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron (2009) 5.20
The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology (2000) 5.14
Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci Transl Med (2013) 4.62
Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) (1987) 4.39
Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics (2013) 4.30
A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci (2009) 3.89
Sustained translational repression by eIF2α-P mediates prion neurodegeneration. Nature (2012) 3.54
Association of different adverse life events with distinct patterns of depressive symptoms. Am J Psychiatry (2007) 2.90
Immunochemical characterization of inhibitory mouse cortical neurons: three chemically distinct classes of inhibitory cells. J Comp Neurol (2010) 2.84
The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev (2005) 2.74
New insights into the classification and nomenclature of cortical GABAergic interneurons. Nat Rev Neurosci (2013) 2.65
Unique functional properties of somatostatin-expressing GABAergic neurons in mouse barrel cortex. Nat Neurosci (2012) 2.63
Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits. Nat Neurosci (2013) 2.35
Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat Rev Neurosci (2014) 2.25
A molecular signature of depression in the amygdala. Am J Psychiatry (2009) 2.18
Suppression of PKR promotes network excitability and enhanced cognition by interferon-γ-mediated disinhibition. Cell (2011) 1.89
Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress. Behav Brain Res (2004) 1.85
GABAergic interneurons shape the functional maturation of the cortex. Neuron (2013) 1.79
Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat Genet (2013) 1.63
Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol Psychiatry (2011) 1.48
Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat Genet (2003) 1.46
Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology (2008) 1.42
GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. Int J Neuropsychopharmacol (2011) 1.38
The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry (2012) 1.31
Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone. Proc Natl Acad Sci U S A (1973) 1.31
Specificity and timing of neocortical transcriptome changes in response to BDNF gene ablation during embryogenesis or adulthood. Mol Psychiatry (2006) 1.30
Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder. Am J Psychiatry (2012) 1.28
Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol Psychiatry (2001) 1.28
Somatostatinergic systems in brain: networks and functions. Mol Cell Endocrinol (2007) 1.26
Anxiogenic-like effect of chronic corticosterone in the light-dark emergence task in mice. Behav Neurosci (2006) 1.24
Brain-specific disruption of the eIF2α kinase PERK decreases ATF4 expression and impairs behavioral flexibility. Cell Rep (2012) 1.24
Genetic inactivation of the Serotonin(1A) receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety. J Neurosci (2000) 1.16
Reduced somatostatin in subgenual anterior cingulate cortex in major depression. Neurobiol Dis (2011) 1.13
Morphology, distribution, and synaptic relations of somatostatin- and neuropeptide Y-immunoreactive neurons in rat and monkey neocortex. J Neurosci (1984) 1.13
Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1. Proc Natl Acad Sci U S A (2014) 1.11
Amygdala transcriptome and cellular mechanisms underlying stress-enhanced fear learning in a rat model of posttraumatic stress disorder. Neuropsychopharmacology (2010) 1.10
Increased ER stress during motor neuron degeneration in a transgenic mouse model of amyotrophic lateral sclerosis. Neurol Res (2007) 1.07
Activity-dependent brain-derived neurotrophic factor expression regulates cortistatin-interneurons and sleep behavior. Mol Brain (2011) 1.03
Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: relevance to emotionality and sex. J Neurosci Methods (2011) 1.02
Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target? Front Pharmacol (2013) 1.02
Impairment in motor learning of somatostatin null mutant mice. Brain Res (2001) 0.97
Neurabin in the anterior cingulate cortex regulates anxiety-like behavior in adult mice. Mol Brain (2011) 0.96
Opposing effects of acute versus chronic blockade of frontal cortex somatostatin-positive inhibitory neurons on behavioral emotionality in mice. Neuropsychopharmacology (2014) 0.96
Cortistatin--functions in the central nervous system. Mol Cell Endocrinol (2008) 0.96
Brain somatostatin: a candidate inhibitory role in seizures and epileptogenesis. Eur J Neurosci (1999) 0.94
A human-mouse conserved sex bias in amygdala gene expression related to circadian clock and energy metabolism. Mol Brain (2011) 0.94
Cortistatin is expressed in a distinct subset of cortical interneurons. J Neurosci (1997) 0.91
Models of depression: unpredictable chronic mild stress in mice. Curr Protoc Pharmacol (2013) 0.90
Brain somatostatin receptors are up-regulated in somatostatin-deficient mice. Mol Endocrinol (2002) 0.90
Somatostatin analog: plasma catecholamine suppression mediated by the central nervous system. Endocrinology (1980) 0.89
Somatostatinergic systems: an update on brain functions in normal and pathological aging. Front Endocrinol (Lausanne) (2012) 0.89
Everything has rhythm: focus on glucocorticoid pulsatility. Endocrinology (2008) 0.89
Compensatory changes in the hippocampus of somatostatin knockout mice: upregulation of somatostatin receptor 2 and its function in the control of bursting activity and synaptic transmission. Eur J Neurosci (2006) 0.89
Dendritic-targeting GABA neurons in monkey prefrontal cortex: comparison of somatostatin- and calretinin-immunoreactive axon terminals. Synapse (2008) 0.89
Central nervous system regulation of adrenocorticotropin secretion: role of somatostatins. Endocrinology (1984) 0.89
Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion. Neuroendocrinology (1993) 0.86
Central administration of pan-somatostatin agonist ODT8-SST prevents abdominal surgery-induced inhibition of circulating ghrelin, food intake and gastric emptying in rats. Neurogastroenterol Motil (2011) 0.86
Area-specific effects of brain-derived neurotrophic factor (BDNF) genetic ablation on various neuronal subtypes of the mouse brain. Brain Res Dev Brain Res (2005) 0.85
ER stress-induced eIF2-alpha phosphorylation underlies sensitivity of striatal neurons to pathogenic huntingtin. PLoS One (2014) 0.85
Circadian modulation of anxiety: a role for somatostatin in the amygdala. PLoS One (2013) 0.81
Anxiolytic-like effects of somatostatin isoforms SST 14 and SST 28 in two animal models (Rattus norvegicus) after intra-amygdalar and intra-septal microinfusions. Psychopharmacology (Berl) (2011) 0.81
Low levels of somatostatin in human CSF mark depressive episodes. Psychoneuroendocrinology (1984) 0.81
The anxiolytic effects of somatostatin following intra-septal and intra-amygdalar microinfusions are reversed by the selective sst2 antagonist PRL2903. Pharmacol Biochem Behav (2011) 0.81
CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures. Psychoneuroendocrinology (1993) 0.80
Somatostatin administration modifies food intake, body weight, and gut motility in rat. Peptides (1998) 0.79
Attenuated BDNF-induced upregulation of GABAergic markers in neurons lacking Xbp1. Biochem Biophys Res Commun (2008) 0.79
CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression. Biol Psychiatry (1991) 0.78
Plasma dexamethasone concentrations and cortisol suppression response in patients with endogenous depression. J Clin Endocrinol Metab (1980) 0.78
Somatostatin inhibits the effect of secretin on bile flow and on hepatic bilirubin transport in the rat. Gut (1989) 0.76
Central actions of somatostatin-28 and oligosomatostatin agonists to prevent components of the endocrine, autonomic and visceral responses to stress through interaction with different somatostatin receptor subtypes. Curr Pharm Des (2013) 0.76